3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycystic Ovary Syndrome
14
Breast Neoplasms
11
Prostatic Neoplasms
9
Obesity
7
Insulin Resistance
6
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
4
Colorectal Neoplasms
4
Motor Activity
3
Adenocarcinoma of Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Neoplasms
2
Menstruation Disturbances
2
Lymphoma, Large B-Cell, Diffuse
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Diabetes Mellitus
2
Weight Loss
1
Urothelial Cancer
1
Thyroid Diseases
1
Thoracic Neoplasms
1
Smoldering Multiple Myeloma
1
Rectal Neoplasms
1
Prediabetic State
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Overweight
1
Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
1
Non-alcoholic Fatty Liver Disease
1
Interventions
Everolimus
16
Octreotide
6
pembrolizumab
5
lanreotide
5
Sunitinib
5
Magnetic Resonance Spectroscopy
5
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
lenvatinib
3
arginyllysine
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
pasireotide
2
lutetium Lu 177 dotatate
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Temozolomide
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroendocrine Tumors
×
Metformin
×
Clear all
No trials found.